References
- Sprengers E D, Kluft C. Plasminogen activator inhibitors. Blood 1987; 69: 381–7
- Lin G HY, Voss K A, Davidson T J. Acute inhalation toxicity of cetylpyridinium chloride. Food Chem Toxicol 1991; 29: 851–4
- Meier J, Stocker K. Effects of snake venoms on hemostasis. Crit Rev Toxicol 1991; 21: 171–82
- Corrigan J J, Jeter M A. Mojave rattlesnake venom—in vitro effect on platelets, fibrinolysis, and fibrinogen clotting. Vet Hum Toxicol 1990; 32: 439–41
- Francis R B. Clinical disorders of fibrinolysis: a critical review. Blut 1989; 59: 1–14
- Maiello M, Boeri D, Podesta F, et al. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes 1992; 41: 1009–15
- Moon J G, Chung S K, Myong Y W, et al. Treatment of postcataract fibrinous membranes with tissue plasminogen activator. Ophthalmology 1992; 99: 1256–9
- Riley M V, Green K. Comparative physiology and biochemistry of the eye. Manual of oculotoxicity testing of drugs, O Hockwin, K Green, L F Rubin. Gustav Fischer Verlag, Stuttgart 1992; 45–65
- Eakins K E. Prostaglandin and non-prostaglandin mediated breakdown of the blood-aqueous barrier. Exp Eye Res 1977; 25: 483–98
- Harroff H H, Jr. Pathological processes of the eye related to chemical exposure. Dermal and ocular toxicology, D W Hobson. CRC Press, Boca Raton 1991; 493–508
- Tripathi R C, Park J K, Tripathi B J, Millard C B. Tissue plasminogen activator in human aqueous humor and its possible therapeutic significance. Am J Ophthalmol 1988; 106: 719–22
- Wilkie D A, Wyman M. Comparative anatomy and physiology of the mammalian eye. Dermal and ocular toxicology, D W Hobson. CRC Press, Boca Raton 1991; 433–92
- Bernatchez S F, Tabatabay C, Belin D. Urokinase-type plasminogen activator in human aqueous humor. Invest Ophthalmol Vis Sci 1992; 33: 2687–92
- Gerding P A, Essex-Sorlie D, Vasaune S, Yack R. Use of tissue plasminogen activator for intraocular fibrinolysis in dogs. Am J Vet Res 1992; 53: 894–6
- Gerding P A, Eurell T E. Evaluation of intraocular penetration of topically administered tissue plasminogen activator in dogs. Am J Vet Res 1993; 54: 836–9
- Geanon J D, Tripathi B J, Tripathi R C, Barlow G H. Tissue plasminogen activator in avascular tissues of the eye: a quantitative study of its activity in the cornea, lens, and aqueous and vitreous humors of dog, calf, and monkey. Exp Eye Res 1987; 44: 55–63
- Andreotti F, Kluft C. Orcadian variation of fibrinolytic activity in blood. Chronobiol Int 1991; 8: 336–51